Menu ≡ ╳
The demand for wearables and sensors in clinical trials is on the rise. Pharma companies are increasingly challenged with both rising costs and the need to find novel ways to differentiate the drugs they are developing. One such way is by accessing the clinical data collected on remote medical devices.
By leveraging remote medical devices, there is an opportunity to collect novel endpoints and supplemental data that may improve the regulatory case, make the case for reimbursement more compelling, open up participation to a wider population and/or reduce site visits for patients who may not live close to an investigative site.
However, large volumes of continuous flowing data will increasingly require scalable cloud support along-with a proactive approach to data standardization. Data standardization assumes vital importance because there is large chunks of unstructured data that can overwhelm traditional functions and processes.
A good data standardization platform will enable better clinical data quality management, clinical data review and reduce cycle time by creating submission standard deliverables. An ideal platform should enable –
MaxisIT has shown tremendous success in delivering value based on standardizing over 800 clinical studies. Be it the self-service platform or functional outsourcing, MaxisIT has delivered consistent quality, compliance and cost reduction. If you want to know more please get in touch.
11 May 2018